Disclosures for "Movement Disorders in Two Children with DNM1L-related Mitochondrial Cytopathy "
-
Dr. Sudheendra has nothing to disclose.
-
Ms. Stafford has nothing to disclose.
-
Ms. Kass has nothing to disclose.
-
Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
-
Dr. Hull has received publishing royalties from a publication relating to health care.